ANGPT2 and glioblastoma: The dual inhibition of VEGF/Ang-2 may delay tumor growth and prolong survival in mice with glioblastoma multiforme (GBM) by normalizing tumor vasculature and reprogramming the tumor immune microenvironment via an effect on the phenotypic polarization of tumor macrophages [168,169].